Irina Gorodetskaya, MHA
Clinical Research Supervisor
Surgery
School of Medicine

Publications (4)

Top publication keywords:
Hyperparathyroidism, SecondaryRenal DialysisHeart VentriclesRefusal to ParticipateCost of IllnessCreatinineRenal Insufficiency, ChronicPatient SelectionQuality of LifePatient DropoutsGlomerular Filtration RateKidney Failure, ChronicHealth StatusLongitudinal StudiesHyperphosphatemia

• Challenges to enrollment and randomization of the Frequent Hemodialysis Network (FHN) Daily Trial.
  Journal of nephrology 2012 Sergeyeva O, Gorodetskaya I, Ramos R, Schiller BM, Larive B, Raimann JG, Ting GO, Eggers PW, Chertow GM, Levin NW, Frequent Hemodialysis Network Trials Group
• In-center hemodialysis six times per week versus three times per week.
  The New England journal of medicine 2010 FHN Trial Group, Chertow GM, Levin NW, Beck GJ, Depner TA, Eggers PW, Gassman JJ, Gorodetskaya I, Greene T, James S, Larive B, Lindsay RM, Mehta RL, Miller B, Ornt DB, Rajagopalan S, Rastogi A, Rocco …
• Health-related quality of life and estimates of utility in chronic kidney disease.
  Kidney international 2005 Gorodetskaya I, Zenios S, McCulloch CE, Bostrom A, Hsu CY, Bindman AB, Go AS, Chertow GM
• The severity of secondary hyperparathyroidism in chronic renal insufficiency is GFR-dependent, race-dependent, and associated with cardiovascular disease.
  Journal of the American Society of Nephrology : JASN 2002 De Boer IH, Gorodetskaya I, Young B, Hsu CY, Chertow GM